Diabetes is prevalent in older adults and older adults with diabetes are more likely to have multiple comorbidities. It is, therefore, important to personalize diabetes management in this group. Newer glucose-lowering drugs, including dipeptidyl peptidase-4 inhibitors, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists can be safely used in older patients and are preferred choices in many cases due to their safety, efficacy, and low risk of hypoglycemia.
Keywords: DPP-4 inhibitors; Diabetes subtypes; GLP-1 receptor agonists; Older adults; Precision medicine; SGLT-2 inhibitors; Tirzepatide; Type 2 diabetes.
Published by Elsevier Inc.